XSpray Pharma AB Tangible Net Worth Ratio
XSpray Pharma AB tangible net worth ratio. XSpray Pharma AB (XSPRAY) has a Tangible Net Worth Ratio of 17.6% as of June 2026. This metric is calculated by deducting intangible assets (Skr525.51 Million) from net assets (Skr637.50 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check XSPRAY strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of XSpray Pharma AB (2015–2025)
Tangible net worth ratio of XSpray Pharma AB from 2015 to 2025. This chart shows how XSpray Pharma AB's Tangible Net Worth Ratio has changed across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 17.6%, reflecting net assets of Skr637.50 Million with intangible assets of Skr525.51 Million SEK. See working capital to net assets of XSpray Pharma AB to evaluate short-term liquidity relative to the company's equity base.
XSpray Pharma AB Tangible Net Worth Ratio by Year (2015–2025)
XSpray Pharma AB tangible net worth ratio by year from 2015 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for XSpray Pharma AB from 2015 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see XSPRAY market cap.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 15.3% | Skr604.65 Million | Skr512.19 Million | Skr769.35 Million | ▼ -7.8 pp |
| 2024 | 23.1% | Skr623.10 Million | Skr478.93 Million | Skr796.34 Million | ▼ -13.9 pp |
| 2023 | 37.0% | Skr693.41 Million | Skr436.78 Million | Skr765.26 Million | ▲ +6.4 pp |
| 2022 | 30.7% | Skr556.02 Million | Skr385.60 Million | Skr585.43 Million | ▼ -19.3 pp |
| 2021 | 49.9% | Skr591.75 Million | Skr296.24 Million | Skr622.90 Million | ▼ -10.3 pp |
| 2020 | 60.2% | Skr582.59 Million | Skr231.62 Million | Skr605.30 Million | ▼ -1.9 pp |
| 2019 | 62.1% | Skr373.71 Million | Skr141.51 Million | Skr400.67 Million | ▼ -14.0 pp |
| 2018 | 76.2% | Skr301.72 Million | Skr71.89 Million | Skr312.49 Million | ▲ +2.9 pp |
| 2017 | 73.3% | Skr155.66 Million | Skr41.61 Million | Skr161.41 Million | ▲ +16.6 pp |
| 2016 | 56.7% | Skr46.47 Million | Skr20.12 Million | Skr51.86 Million | ▼ -33.7 pp |
| 2015 | 90.4% | Skr12.26 Million | Skr1.17 Million | Skr14.95 Million | — |